CAGS Meet Week - Revitalizing The Morbidity And Mortality Conference

This is a special episode of Cold Steel done in collaboration with the Canadian Association of General Surgeons (CAGS: www.twitter.com/CAGS_ACCG). In lieu of the annual Canadian Surgical Forum (CSF), CAGS put on a series of fantastic webinars over the week of Nov 26 - 30. These were highly impactful and relevant webinars. Topics included: -The COVID-19 Elective Surgery Crisis and New Models of Surgical Referral and Care- Alone in the Night: Difficult Scenarios in ACS- Revitalizing the Morbidity and Mortality Conference (MMC)- Diversity in Health Research Outcomes In this session, we discussed the challenges facing Morbidity and Mortality Conferences (MMC's) and how we can continue to revitalize this time-honoured tradition. The session was moderated and organized by Ameer Farooq, with Dr. Morad Hameed, Dr. Chelsea Harris, and Dr. Christian Finley as the invited panelists. To check out all the CAGS webinars, please go to the CAGS website (https://cags-accg.ca/). Please consider becoming a member to access all the great content available to CAGS members.Links for M&M's1. Dr. Hameed narrative review paper on MMC's: http://canjsurg.ca/63-3-e211/2. Failure to rescue paper by Dr. Amir Ghaferi: https://www.nejm.org/doi/full/10.1056/nejmsa09030483. The last dance: https://www.netflix.com/ca/title/802031444. Association between technical skill and long-term survival for colon cancer: https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2020.54625. Ethics M&Ms: https://meridian.allenpress.com/jgme/article/8/3/462/189862/Ethics-M-amp-Ms-Toward-a-Recognition-of-Ethics-in6. cultural complications - https://www.culturalcomplications.com/7. ottawa M&M "OM3" model: https://emottawablog.com/2018/03/improving-morbidity-mortality-rounds-om3/8. Positive deviance for continuous quality improvement: https://pubmed.ncbi.nlm.nih.gov/26188970/9. Pan-Canadian standards for Cancer Surgery (Finley): https://pubmed.ncbi.nlm.nih.gov/31364830/

There are no comments yet.

Please log in to write the first comment.